Railway Pension Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-88,100
Closed -$10.2M 237
2023
Q3
$10.2M Hold
88,100
0.11% 156
2023
Q2
$9.06M Hold
88,100
0.09% 165
2023
Q1
$9.62M Hold
88,100
0.1% 154
2022
Q4
$10M Buy
88,100
+29,500
+50% +$2.45M 0.1% 151
2022
Q3
$3.63M Hold
58,600
0.04% 199
2022
Q2
$4.67M Buy
+58,600
New +$5.55M 0.05% 189
2022
Q1
Sell
-25,500
Closed -$2.75M 258
2021
Q4
$2.75M Buy
+25,500
New +$2.78M 0.02% 225

Other funds holding HZNP

Railway Pension Investments's HZNP Position: Q4 2023 in Review

Railway Pension Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 88,100 shares — an estimated $10.2M sold.

Railway Pension Investments first reported a position in HZNP in Q4 2021 and held it in 7 quarters. The position peaked at $10.2M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Railway Pension Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Railway Pension Investments sold 88,100 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $10.2M.
  • Railway Pension Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 7 quarters.
  • Railway Pension Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $10.2M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Railway Pension Investments's 13F filing for Q4 2023, filed 12 Feb 2024.